Novo Nordisk's stock price fell more than 17% in pre-market trading in the U.S. after the release of the Cagrisema data.
Novo Nordisk's stock price fell more than 17% in pre-market trading in the US
2024-12-20 18:49:55
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights
A-share SMIC rose more than 5%
2024-12-27